Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
European Urology Focus|September 23, 2020
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the ProstateAlexander Kretschmer, Elio Mazzone, Francesco Barletta, et al.
European Urology Oncology|June 9, 2024
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome SignatureIsabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Urologic Oncology|February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective studyEmily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.
Clinical Genitourinary Cancer|November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World AnalysisGiulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 11, 2024
Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI PathwayMaria Frantzi, Ana C Morillo, Guillermo Lendinez, et al.
World Journal of Urology|November 2, 2020
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancerC Surcel, C Mirvald, I Tsaur, et al.
European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
European Urology Oncology|January 10, 2021
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate CancerThomas Steuber, Isabel Heidegger, Mona Kafka, et al.
European Urology Focus|September 23, 2020
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the ProstateAlexander Kretschmer, Elio Mazzone, Francesco Barletta, et al.
European Urology Oncology|June 9, 2024
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome SignatureIsabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
European Urology Oncology|February 22, 2023
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical ReviewFrancesco Mattana, Lorenzo Muraglia, Pawel Rajwa, et al.
Urologic Oncology|February 21, 2026
Progression-free survival with darolutamide and docetaxel vs. androgen receptor pathway inhibitors vs. docetaxel in metastatic hormone-sensitive prostate cancer: A real-world multicenter retrospective studyEmily Rinderknecht, Gloria Bielstein, Richard Cathomas, et al.
Clinical Genitourinary Cancer|November 28, 2024
Safety and Efficacy of <sup>177</sup>Lu-PSMA Therapy Following <sup>223</sup>Radium Treatment: A Retrospective Multinational Real-World AnalysisGiulia Giannini, Mona Kafka, Hannes Neuwirt, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 11, 2024
Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI PathwayMaria Frantzi, Ana C Morillo, Guillermo Lendinez, et al.
World Journal of Urology|November 2, 2020
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancerC Surcel, C Mirvald, I Tsaur, et al.
European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.
Pageof 16